B

Berclaz, Luc M.; Burkhard-Meier, Anton; Lechner, Axel; Völkl, Michael; Güler, Sinan E.; Abdel-Rahman, Sultan; Mansoorian, Sina; Kunz, Wolfgang G.; Knösel, Thomas; Canis, Martin; von Bergwelt-Baildon, Michael; Issels, Rolf D.; Di Gioia, Dorit; Lindner, Lars H. (2025): Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinoma. Cancer Immunology, Immunotherapy, 74: 174. ISSN 1432-0851

Blobner, Jens; Dengler, Laura; Eberle, Constantin; Herold, Julika J.; Xu, Tao; Beck, Alexander; Mühlbauer, Anton; Müller, Katharina J.; Teske, Nico; Karschnia, Philipp; van den Heuvel, Dominic; Schallerer, Ferdinand; Ishikawa-Ankerhold, Hellen; Thon, Niklas; Tonn, Joerg-Christian; Subklewe, Marion; Kobold, Sebastian; Harter, Patrick N.; Buchholz, Veit R.; von Baumgarten, Louisa (2024): PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis. Cancer Immunology, Immunotherapy, 73: 255. ISSN 1432-0851

R

Reischer, Anna; Leutbecher, Alexandra; Hiller, Björn; Perini, Enrico; White, Kieron; Hernández-Cáceres, Alejandra; Schele, Alexandra; Tast, Benjamin; Rohrbacher, Lisa; Winter, Lis; Czogalla, Bastian; Mahner, Sven; Flaswinkel, Heinrich; Leonhardt, Heinrich; Wyder, Lorenza; Wichmann, Christian; Maenner, Denis; Trillsch, Fabian; Kessler, Mirjana; Hopfner, Karl-Peter; Fenn, Nadja C.; Subklewe, Marion (2025): Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy. Cancer Immunology, Immunotherapy, 74: 214. ISSN 1432-0851

S

Stock, Sophia; Fertig, Luisa; Gottschlich, Adrian; Dörr, Janina; Märkl, Florian; Majed, Lina; Menkhoff, Vivien D.; Grünmeier, Ruth; Rejeski, Kai; Cordas dos Santos, David M.; Theurich, Sebastian; von Bergwelt-Baildon, Michael; Endres, Stefan; Subklewe, Marion; Kobold, Sebastian (2024): Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma. Cancer Immunology, Immunotherapy, 73 (6). ISSN 1432-0851